SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 232 filers reported holding SAGE THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.89 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2020 | $276,000 | -48.8% | 3,200 | -83.0% | 0.23% | -20.3% |
Q1 2020 | $539,000 | -89.4% | 18,800 | -32.6% | 0.29% | -19.2% |
Q2 2019 | $5,108,000 | +248.7% | 27,900 | +82.4% | 0.35% | +250.5% |
Q4 2018 | $1,465,000 | +48.3% | 15,300 | +118.6% | 0.10% | +77.2% |
Q3 2018 | $988,000 | -77.3% | 7,000 | -90.0% | 0.06% | -75.5% |
Q3 2017 | $4,354,000 | -21.8% | 69,900 | 0.0% | 0.23% | -32.1% |
Q2 2017 | $5,566,000 | +36.2% | 69,900 | +21.6% | 0.34% | +32.9% |
Q1 2017 | $4,086,000 | +1031.9% | 57,500 | +379.2% | 0.26% | +658.8% |
Q2 2016 | $361,000 | -82.8% | 12,000 | -81.7% | 0.03% | -84.0% |
Q1 2016 | $2,099,000 | +443.8% | 65,500 | +750.6% | 0.21% | +292.6% |
Q1 2015 | $386,000 | +57.6% | 7,700 | +14.9% | 0.05% | +31.7% |
Q4 2014 | $245,000 | – | 6,700 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
RA Capital Management | 455,173 | $74,972,000 | 6.27% |
Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |